tert-butyl ((3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl)-carbamate | 881656-96-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡喃
• 英文名称: tert-butyl ((3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl)-carbamate
• 英文别名: (3R,6S)-(6-carbamoyl-tetrahydro-pyran-3-yl)-carbamic acid tert-butyl ester；tert-butyl [(3R,6S)-6-(aminocarbonyl)tetrahydro-2H-pyran-3-yl]carbamate；tert-butyl [(3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl]carbamate；tert-butyl N-[(3R,6S)-6-carbamoyloxan-3-yl]carbamate
• CAS: 881656-96-8
• 化学式: C₁₁H₂₀N₂O₄
• 分子量: 244.291
• InChiKey: ABKQDNYYKUYMQD-SFYZADRCSA-N

物化性质

• 沸点：
  446.3±45.0 °C(Predicted)
• 密度：
  1.15±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.82
• 拓扑面积：
  90.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  tert-butyl ((3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl)-carbamate 在 tris(dibenzylideneacetone)dipalladium(0) chloroform complex 、 caesium carbonate 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 、 三氟乙酸 作用下， 以 1,4-二氧六环 、 甲醇 、 1,2-二氯乙烷 为溶剂， 反应 3.0h， 生成 (2S,5R)-N-(6-methoxy-1,5-naphthyridin-4-yl)-5-(((3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]thiazin-6-yl)methyl)amino)tetrahydro-2H-pyran-2-carboxamide
  参考文献：
  名称：

  Design, Synthesis, and Characterization of Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram-Positive Activity

  摘要：

  There is an urgent need for new antibacterial drugs that are effective against infections caused by multidrug-resistant pathogens. Novel nonfluoroquinolone inhibitors of bacterial type II topoisomerases (DNA gyrase and topoisomerase IV) have the potential to become such drugs because they display potent antibacterial activity and exhibit no target-mediated cross-resistance with fluoroquinolones. Bacterial topoisomerase inhibitors that are built on a tetrahydropyran ring linked to a bicyclic aromatic moiety through a syn-diol linker show potent anti-Gram-positive activity, covering isolates with clinically relevant resistance phenotypes. For instance, analog 49c was found to be a dual DNA gyrase topoisomerase IV inhibitor, with broad antibacterial activity and low propensity for spontaneous resistance development, but suffered from high hERG K channel block. On the other hand, analog 49e displayed lower hERG K channel block while retaining potent in vitro antibacterial activity and acceptable frequency for resistance development. Furthermore, analog 49e showed moderate clearance in rat and promising in vivo efficacy against Staphylococcus aureus in a murine infection model.

  DOI：

  10.1021/jm400963y
• 作为产物：
  描述：

  (2S,5R)-5-[(叔-丁氧羰基)氨基]四氢-2H-吡喃-2-羧酸 在 N-甲基吗啉 、 氯化铵 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 以84%的产率得到tert-butyl ((3R,6S)-6-carbamoyltetrahydro-2H-pyran-3-yl)-carbamate
  参考文献：
  名称：

  WO2006/125974

  摘要：

  公开号：

文献信息

• DISPIROPYRROLIDINE DERIVATIVES
  申请人：Sugimoto Yuuichi

  公开号：US20120264738A1

  公开（公告）日：2012-10-18

  A compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1), which has various substituents, inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R 1 , R 2 , R 3 , ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.

  提供了一种抑制小鼠双分子2（Mdm2）蛋白与p53蛋白相互作用并具有抗肿瘤活性的化合物。本发明提供了以下式（1）所代表的二螺环吡咯烷衍生物，其具有各种取代基，抑制Mdm2蛋白与p53蛋白之间的相互作用并具有抗肿瘤活性，其中式（1）中的R1、R2、R3、环A和环B分别具有规范中定义的相同含义。
• [EN] DISPIROPYRROLIDINE DERIVATIVE<br/>[FR] DÉRIVÉ DE DISPIROPYRROLIDINE
  申请人：DAIICHI SANKYO CO LTD

  公开号：WO2012121361A1

  公开（公告）日：2012-09-13

  Ｍｄｍ２（ｍｕｒｉｎｅ　ｄｏｕｂｌｅ　ｍｉｎｕｔｅ　２）タンパク質とｐ５３タンパク質との相互作用を阻害し、抗腫瘍活性を示す新規化合物を提供すること。 本発明は、Ｍｄｍ２タンパク質とｐ５３タンパク質との相互作用を阻害し、抗腫瘍活性を示す、各種置換基を有する下記式（１）で表されるジスピロピロリジン誘導体を提供する（ここで、式（１）中のＲ１、Ｒ２、Ｒ３、環Ａおよび環Ｂは、それぞれ、明細書中の定義と同義である。）。

  本发明提供了一种新型化合物，其具有下述式（1）所示的二噻吩并[3.2.1]壬烯衍生物，该化合物可以阻止Mdm2蛋白和p53蛋白的相互作用，并表现出抗肿瘤活性（其中，式（1）中的R1，R2，R3，环A和环B分别与说明书中的定义同义）。
• Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity
  申请人：Reck Folkert

  公开号：US20090131444A1

  公开（公告）日：2009-05-21

  The present invention relates to compounds that demonstrate antibacterial activity, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment of bacterial infections in warm blooded animals such as humans. In particular this invention relates to compounds useful for the treatment of bacterial infections in warm-blooded animals such as humans, more particularly to the use of these compounds in the manufacture of medicaments for use in the treatment of bacterial infections in warm blooded animals such as humans.

  本发明涉及表现出抗菌活性的化合物、其制备过程、包含它们作为活性成分的药物组合物、它们作为药物的使用以及它们在制造用于治疗温血动物（如人类）的细菌感染的药物方面的使用。特别地，本发明涉及用于治疗温血动物（如人类）细菌感染的有用化合物，更具体地涉及使用这些化合物制造用于治疗温血动物（如人类）细菌感染的药物。
• DISPIROPYRROLIDINE DERIVATIVE
  申请人：Daiichi Sankyo Company, Limited

  公开号：EP2684880A1

  公开（公告）日：2014-01-15

  A novel compound that inhibits interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity is provided. The present invention provides a dispiropyrrolidine derivative represented by the following formula (1) having various substituents that inhibits interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity, wherein R1, R2, R3, ring A, and ring B in formula (1) respectively have the same meanings as defined in the specification.

  本发明提供了一种新型化合物，它能抑制小鼠双分 2（Mdm2）蛋白和 p53 蛋白之间的相互作用，并具有抗肿瘤活性。本发明提供了一种由下式（1）表示的二吡咯烷衍生物，该衍生物具有各种取代基，可抑制 Mdm2 蛋白和 p53 蛋白之间的相互作用并具有抗肿瘤活性，其中式（1）中的 R1、R2、R3、环 A 和环 B 分别具有与说明书中所定义的相同的含义。
• WO2007/105154
  申请人：——

  公开号：——

  公开（公告）日：——